- Report
- December 2023
- 151 Pages
Global
From €3642EUR$4,000USD£3,124GBP
From €4507EUR$4,950USD£3,866GBP
- Report
- June 2023
Global
From €4507EUR$4,950USD£3,866GBP
- Report
- February 2020
- 72 Pages
Indonesia
From €2731EUR$3,000USD£2,343GBP
- Report
- August 2025
- 232 Pages
Global
From €2276EUR$2,500USD£1,953GBP
- Report
- August 2025
- 182 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 198 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 183 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- August 2025
- 190 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- May 2025
- 70 Pages
Canada
From €3187EUR$3,500USD£2,734GBP
- Report
- February 2025
- 85 Pages
India
From €3187EUR$3,500USD£2,734GBP
From €3187EUR$3,500USD£2,734GBP
- Report
- December 2024
- 83 Pages
Saudi Arabia
From €3187EUR$3,500USD£2,734GBP
- Report
- December 2024
- 82 Pages
Indonesia
From €3187EUR$3,500USD£2,734GBP
- Report
- December 2024
- 85 Pages
India
From €3187EUR$3,500USD£2,734GBP
- Report
- November 2024
- 82 Pages
Vietnam
From €3187EUR$3,500USD£2,734GBP
- Report
- October 2024
- 89 Pages
Egypt
From €3187EUR$3,500USD£2,734GBP
- Report
- August 2024
- 80 Pages
Japan
From €3187EUR$3,500USD£2,734GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3187EUR$3,500USD£2,734GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3187EUR$3,500USD£2,734GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more